Nabi Kamyabi

About Nabi Kamyabi

As a seasoned Medical Science Liaison covering 5 states I bring years of experience across immunology, dermatology, gastroenterology, and genetics. I have built and strengthened relationships with more than 250 healthcare professionals, including leading dermatologists and allergy/immunology specialists across the US, partnering with Key Opinion Leaders (KOLs) to advance scientific exchange and improve patient care.In my role as a Dermatology MSL, I have led high-impact scientific engagements centered on Nemolizumab, sharing the latest clinical data and real-world insights to support evidence-based decision making. I have organized and moderated advisory boards, roundtable discussions, and educational dinner programs, facilitating meaningful dialogue among experts and translating field insights into actionable strategies for the organization. My ability to synthesize scientific discussions and deliver clear, strategic feedback has consistently contributed to cross-functional alignment and informed business decisions.My background includes hands-on clinical research experience at MD Anderson Cancer Center, where I contributed to clinical studies focused on early detection technologies for pancreatic cancer. Throughout my career, I have contributed to 12 peer-reviewed publications and presented at more than 15 national and international conferences, including AACR and AAI, reflecting my commitment to advancing science and patient outcomes.I combine deep scientific expertise with strong KOL engagement and business acumen, enabling me to serve as a trusted scientific partner while driving collaboration and innovation.Outside of work, I enjoy photography, hiking, biking, and traveling—experiences that continue to broaden my perspective and enrich both my professional and personal growth.

Experience

1. Medical Science Liaison - Immunology Dermatology

   Galderma

   Mar 2025 — Present

   Serve as a field-based scientific expert in dermatology and immunology, leading non-promotional scientific exchange with dermatology KOLs on disease biology and innovative therapies focusing on nemolizumab (Nemluvio). • Build and maintain strategic, long-term relationships with national and regional KOLs, academic investigators, and community dermatologists across assigned territory.• Capture and communicate actionable medical insights to cross-functional teams (Medical Affairs, Clinical Development, Market Access) to inform medical strategy and patient-focused outcomes.• Support clinical research activities, including investigator-initiated studies (IIS), clinical trial feasibility assessments, site identification, and ongoing investigator engagement.•. Provide Medical support for payer and access discussions, addressing clinical value, trial design, and real-world relevance of Galderma therapies when appropriate.

Education

• Sharif University of Technology

  Bachelor of Science - BS, Chemical Engineering

  2003 — 2007

• Texas Tech University

  Doctor of Philosophy (Ph.D.), Chemical/Biomedical engineering

  2012 — 2017

• Sharif University of Technology

  Master of Science - MS, Chemical and Biomolecular Engineering

  2007 — 2010